SAFE & EFFECTIVE LASER TREATMENT FOR CHRONIC PAIN
Now you can relieve your pain and inflammation associated with chronic pain. Our new FDA market cleared laser has been proven in clinical tests to effectively treat chronic pain. The healing powers of this low level laser technology can get you back to an active lifestyle in only a manner of weeks!
NO PAIN | NO SIDE EFFECTS | NO DOWNTIME
FX 405 Laser
The FX 405 uses low-level laser technology and patented laser diode arms to precisely target pain centers. The body absorbs the light energy, which encourages the cell’s mitochondria to produce more ATP and promotes natural healing within the cell. Because the laser merely stimulates the cells to promote healing naturally, the FX 405 provides pain relief and reduces inflammation with no adverse side effects.
Chronic Low Back Pain
About 80 percent of adults experience low back pain at some point in their lifetimes. Of those, about 60% are treated with opioids, despite the opioid epidemic and minimum effectiveness (30%). Erchonia’s FX 635 laser showed a 72% success rate in their clinical trial, which received FDA market clearance in May 2018. The FX 635 treatment of chronic low back pain is groundbreaking in the pain management community and give patients a safer, more effective treatment option that will get them back on their feet in no time.
Neck and Shoulder Pain
Erchonia low level lasers are proven to be effective in reducing and eliminating chronic pain in the neck & shoulders. Many patients find that this solution is a much more effective and immediate alternative to traditional pain medications. The Erchonia lasers have been proven through rigorous clinical trials in which subjects had to refrain from any therapies, beside the laser. However in practice doctors are combining with forms of chiropractors and therapy, to help patients lead a normal, active, and healthy life without debilitating pain.
Plantar fasciitis is the most common cause of heel pain in adults, affecting 1 million persons each year in the United States. Treatment ranges from rest to surgical intervention. Erchonia’s LLLT has received FDA clearance as an adjunct treatment for Plantar Fasciitis due to the treatment’s safe and efficacious nature. In a 3 week study, on average individuals experienced a 50% reduction in pain, with pain reduction either improving or sustaining up to 12 months post treatment
Onychomycosis is an infection of the finger or toenails causing the unsightly appearance of nails. Current therapies include oral and topical medications, however medications do come with a risk of possible side effects. Another treatment option is Erchonia’s LLLT which received FDA Clearance in 2016. The treatment involves only 4 non-thermal laser sessions with no known side effects.
Q. What is low-level laser therapy (3LT®)?
A. Low-level laser therapy is the use of low intensity photonic energy as a treatment modality.
Q. How does Low-Level Laser (3LT®) work?
A. Photonic stimuli excite the body’s cells infusing them with energy, with the three primary reactions being, reduction of inflammation, cell function and increased blood flow.
Q. What are the benefits of low-laser therapy?
A. Low level laser therapy is a non-invasive, fast and effective modality that has been proven in clinical trials to reduce pain, reduce edema, and promote healing.
Q. How safe is low-level laser therapy (3LT®)?
A. Low level laser therapy has is very safe; the only general precaution is the use of special filtering glasses when a class 3B laser is in use.
Evaluation of Low-Level Laser Therapy at 635nm for the Treatment of Acute and Chronic Neck and Shoulder Pain: A Placebo-Controlled, Randomized Study
Laser in Surgery Medicine 2014, Volume 46, Number S25, March 2014 Ryan Maloney, Steven Shanks
Phoenix, AZ; Erchonia Corporation, McKinney, TX
Low-Level Laser Therapy for the Treatment of Chronic Neck and Shoulder Pain
Funct Neurol Rehabil Ergon 2016;6(2):97-104
Gregory C. Roche; Daniel J. Murphy; Trevor S. Berry; Steven Shanks
Effects of a Single Treatment with Two Non-Thermal Wavelengths on Chronic Neck and Shoulder Pain
Dove Press Journal, Medical Devices: Evidence and Research 2019:12 319–325
Robert G. Silverman, Albert Comey, Travis Sammons